Biopharmaceutical intermediate project of Zhulong Biotechnology

On 2 August, the environmental impact assessment (EIA) of Zhejiang Zhulong Biotechnology Co., Ltd. (Zhulong Biotechnology)'s biopharmaceutical intermediate project was publicised. With a total investment of RMB10 million (USD1.40 million), the compan...

Vitamins China E-News 202408

www.cnchemicals.com